Targeting KSHV/HHV-8 Latency with COX-2 Selective Inhibitor Nimesulide: A Potential Chemotherapeutic Modality for Primary Effusion Lymphoma (Q21135231)
Jump to navigation
Jump to search
scientific article published on September 30, 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Targeting KSHV/HHV-8 Latency with COX-2 Selective Inhibitor Nimesulide: A Potential Chemotherapeutic Modality for Primary Effusion Lymphoma |
scientific article published on September 30, 2011 |
Statements
Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma (English)
0 references
Targeting KSHV/HHV-8 Latency with COX-2 Selective Inhibitor Nimesulide: A Potential Chemotherapeutic Modality for Primary Effusion Lymphoma (English)
1 reference
Arun George Paul
1 reference
Neelam Sharma-Walia
1 reference
Bala Chandran
1 reference
2011
0 references
30 September 2011
6
0 references
9
0 references
e24379
0 references
30 September 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference